Mark Cohen
President · Carle Illinois College of Medicine
Credentials: · · · · · ·
History
- Present
Research
Old and New Approaches to Target the Hsp90 Chaperone
Review · Current Cancer Drug Targets · 2020 · 153 citations
LIMIT is an immunogenic lncRNA in cancer immunity and immunotherapy
Nature Cell Biology · 2021 · 146 citations
The discovery of vemurafenib for the treatment of BRAF-mutated metastatic melanoma
Review · Expert Opinion on Drug Discovery · 2016 · 132 citations
12 papers
12 papers
12 papers · 5 as a fellow
12 papers
- DC
9 papers · 9 as a resident
9 papers
- PG
9 papers · 3 as a resident
8 papers · 8 as a resident
